医学
贝里穆马布
内科学
加药
回顾性队列研究
结缔组织病
外科
胃肠病学
疾病
自身免疫性疾病
免疫学
抗体
B细胞激活因子
B细胞
作者
Íñigo Rúa‐Figueroa,Irene Altabás‐González,C. Mouriño,Karen Roberts,Andrea Hernández-Martín,I. Casafont-Solé,J. Font,José Andrés Román‐Ivorra,Marta Navarro,María Galindo,Tarek Carlos Salman-Monte,Javier Narváez,Paola Vidal-Montal,María Jesús García-Villanueva,Sandra Garrote-Corral,María Ángeles Blázquez-Cañamero,Carlos Marras,María Piqueras-García,Julia Martínez‐Barrio,Marina Sánchez‐Lucas
标识
DOI：10.1093/rheumatology/keae270
摘要
The aims of this study were to investigate the prevalence of dose reduction in patients with SLE treated with belimumab (BEL) in Spain, analyze treatment modalities, and determine impact on control of disease activity.
科研通智能强力驱动
Strongly Powered by AbleSci AI
Grayball
迟大猫
开心岩
MchemG
VDC
迷人秋烟
小白
iNk
竹筏过海
笔记本
YSM
小杨同学
遇上就这样吧
Xiaoxiao
zho
morena
青木香
nozero
从容芮
归尘
皖公网安备34019202002308
